Role of surgery in mild primary hyperparathyroidism in the elderly

British Journal of Surgery

Volumn 87, Issue 12, 2000, Pages 1640-1649

  Roche, N A ^a   Young, A E ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; ELDERLY CARE; HUMAN; HYPERPARATHYROIDISM; MEDICAL INFORMATION; PARATHYROIDECTOMY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

AGED; BONE DISEASES; CARDIOVASCULAR DISEASES; HUMANS; HYPERPARATHYROIDISM; MENTAL DISORDERS; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PARATHYROIDECTOMY; PROSPECTIVE STUDIES;

EID: 0033663287     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2000.01628.x     Document Type: Review

References (62)

1. Therapeutischer versuch bei ostitis fibrosa generalisata mittels exstirpation eines epithelkorperchentumors
2. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community
3. Sex, age, and hyperparathyroidism
4. Primary hyperparathyroidism: Changes in the pattern of clinical presentation
5. Conservative management of primary hyperparathyroidism
6. Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: Clinical course and considerations bearing on the need for surgical intervention
7. Clinical review 9: Management of asymptomatic hyperparathyroidism
8. Asymptomatic primary hyperparathyroidism. 10-Year prospective study
9. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus development conference statement
10. Long-term health risk of primary hyperparathyroidism: The effect of surgery
11. Asymptomatic primary hyperparathyroidism
12. Surgical therapy of patients with primary hyperparathyroidism: Long-term benefits
13. Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels
14. Success of cervical exploration for patients with asymptomatic primary hyperparathyroidism
15. Hyperparathyroidism: Experiences with treated and untreated patients
16. Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up
17. Prevalence of hypercalcaemia in a health survey: A 14-year follow-up study of serum calcium values
18. Increased risk of death from primary hyperparathyroidism - An update
19. Premature death in patients operated on for primary hyperparathyroidism
20. Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study
21. Parathyroid adenoma weight and the risk of death after treatment for primary hyperparathyroidism
22. Clinical evaluation of total serum calcium in primary hyperparathyroidism and the risk of death after surgery
23. The influence of surgery on the risk of death in patients with primary hyperparathyroidism
24. Survival after surgical treatment for primary hyperparathyroidism
25. Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism
26. Hypertension in hyperparathyroidism
27. Changes in blood pressure and renal function after parathyroidectomy in primary hyperparathyroidism
28. Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension
29. Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy
30. Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: Effects of surgical treatment
31. Primary hyperparathyroidism: Incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy
32. Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study
33. Asymptomatic primary hyperparathyroidism
34. Seventeen year follow-up study of bone mass in patients with mild asymptomatic hyperparathyroidism some of whom were operated on
35. Characterization and evaluation of asymptomatic primary hyperparathyroidism
36. Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: Evidence for biphasic disease course
37. Histomorphometric assessment of bone disease in mild primary hyperparathyroidism
38. Changes in bone mass and metabolism after surgery for primary hyperparathyroidism
39. Cortical bone mineral content in primary hyperparathyroidism. Changes after parathyroidectomy
40. Long-term irreversibility of bone loss after surgery for primary hyperparathyroidism
41. Back pain and vertebral crush fractures: An unemphasised mode of presentation for primary hyperparathyroidism
42. Interpretation of bone mass determinations as they relate to fracture: Implications for asymptomatic primary hyperparathyroidism
43. Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures
44. Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia
45. Psychologic symptoms before and after parathyroid surgery
46. Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism
47. Myopathy with primary hyperparathyroidism
48. Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism
49. Neuromuscular involvement in primary hyperparathyroidism
50. Neuromuscular disease in primary hyperparathyroidism
51. Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery
52. Muscle strength is improved after parathyroidectomy in patients with primary hyperparathyroidism
53. Muscular performance and fatigue in primary hyperparathyroidism
54. Surgery for primary hyperparathyroidism: Experience with 500 consecutive cases and evaluation of the role of surgery in the asymptomatic patient
55. Surgical treatment of primary hyperparathyroidism: An institutional perspective
56. Diagnosis and management of asymptomatic hyperparathyroidism: Safety, efficacy, and deficiencies in our knowledge
57. Asymptomatic primary hyperparathyroidism in the elderly - A review
58. Asymptomatic primary hyperparathyroidism: The case for conservative management
59. Primary hyperparathyroidism in younger and older patients: Symptoms and outcome of surgery
60. Parathyroidectomy in the elderly: Do the benefits outweigh the risks?
61. Should primary hyperparathyroidism be treated surgically in elderly patients older than 75 years?
62. Case-control study on symptoms and signs of 'asymptomatic' primary hyperparathyroidism